| K252a | IC50 | 360.0 [1] |
| Doramapimod | IC50 | 30000.0 [1] |
| Silmitasertib | IC50 | 17.0 [1] |
| Sulfuretin | IC50 | 2330.0 [1] |
| Gsk-690693 | IC50 | 81.0 [1] |
| JNK Inhibitor VIII | Ki | 1400.0 [1] |
| CID 59604787 | IC50 | 10000.0 [1] |
| 4-(Pyridin-3-ylmethylene)-2-styryloxazol-5(4H)-one | IC50 | 1000.0 [1] |
| 4-Pyridin-3-ylmethylene-2-m-tolyl-4H-oxazol-5-one | IC50 | 713.7 [1] |
| 2-(4-Chloro-phenyl)-4-pyridin-3-ylmethylene-4H-oxazol-5-one | IC50 | 529.5 [1] |
| N-(4-Amino-5-cyano-6-ethoxypyridin-2-yl)acetamide | Ki | 1400.0 [1] |
| 4-Amino-5-chloro-6-ethoxy-pyridine-2-carboxylic acid 4-methanesulfonyl-benzylamide | Ki | 1400.0 [1] |
| 7-Chloro-3-oxo-8-(1,3-thiazol-5-ylmethylamino)-11,16-dioxa-2,4,19,21-tetrazatricyclo[15.3.1.05,10]henicosa-1(20),5,7,9,17(21),18-hexaene-18-carbonitrile | Ki | 1391.0 [1] |
| 1-({4-[(3,4-Dichlorophenyl)methoxy]phenyl}methyl)azetidine-3-carboxylic acid | IC50 | 10000.0 [1] |
| Khk-IN-1 | IC50 | 40000.0 [1] |
| 7-Chloro-8-(3-hydroxypropoxy)-3-oxo-11,17-dioxa-2,4,20,22-tetrazatricyclo[16.3.1.05,10]docosa-1(21),5,7,9,18(22),19-hexaene-19-carbonitrile | Ki | 10000.0 [1] |
| 7-Chloro-8-(3-hydroxypropyl)-3-oxo-11,17-dioxa-2,4,20,22-tetrazatricyclo[16.3.1.05,10]docosa-1(21),5(10),6,8,18(22),19-hexaene-19-carbonitrile | Ki | 10000.0 [1] |
| N-(7-Chloro-19-cyano-3-oxo-11,17-dioxa-2,4,20,22-tetrazatricyclo[16.3.1.05,10]docosa-1(21),5,7,9,18(22),19-hexaen-8-yl)methanesulfonamide | Ki | 10000.0 [1] |
| N-(4-Amino-5-cyano-6-ethoxypyridin-2-yl)-2-(2,5-dimethoxy-4-methylsulfonylphenyl)acetamide | Ki | 1400.0 [1] |
| N-(4-Amino-5-chloro-6-ethoxypyridin-2-yl)-2-(4-methanesulfonyl-2,5-dimethoxyphenyl)acetamide | Ki | 1400.0 [1] |
| N-(4-Amino-5-cyano-6-isopropoxypyridin-2-yl)-2-(4-methanesulfonyl-2,5-dimethoxyphenyl)acetamide | Ki | 1400.0 [1] |
| N-(4-Amino-5-cyano-6-phenylpyridin-2-yl)acetamide | Ki | 1400.0 [1] |
| 3,13-Diazahexacyclo[14.7.0.02,10.04,9.011,15.017,22]tricosa-1(16),2(10),4,6,8,11(15),17,19,21-nonaen-12-one | IC50 | 1000.0 [1] |
| N-[5-(3,4-Dimethoxyphenyl)thieno[2,3-b]pyridin-3-yl]cyclohexanecarboxamide | IC50 | 39820.0 [1] |
| N-[2-Hydroxy-3-(3-nitroso-1H-indol-2-yl)-1H-indol-5-yl]-2,2-dimethylpropanamide | IC50 | 700.0 [1] |
| 2-Phenyl-4-(3-pyridylmethylene)oxazole-5(4H)-one | IC50 | 583.0 [1] |
| N-Propyl-4-({4-[(2,2,2-trifluoroethyl)amino]-1H-pyrrolo[2,3-d]pyrimidin-2-yl}amino)benzamide | IC50 | 1600.0 [1] |
| 7-Chloro-9-ethyl-6-hydroxy-1H,3H,4H,9H-quinolino[2,3-c][1,2]oxazole-3,4-dione | Ki | 27.3 [1] |
| 5-(2-Aminoethyl)-7-(7-(benzo[b]thiophen-2-yl)-1H-indazol-5-yl)-5H-pyrrolo[3,2-d]pyrimidin-2-amine | IC50 | 4300.0 [1] |
| N-[3-[5-[2-(3-Morpholin-4-ylanilino)pyrimidin-4-yl]imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]-2-phenylacetamide | IC50 | 1000.0 [1] |
| 1-[5-Tert-butyl-3-[4-[2-(dimethylamino)ethyl]-5-oxo-1,4-diazepane-1-carbonyl]thiophen-2-yl]-3-(2,3-dichlorophenyl)urea | IC50 | 32000.0 [1] |
| N-[2-[2-Aminoethyl(methyl)amino]-5-[[3-cyano-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-5-yl]amino]phenyl]acetamide | IC50 | 10.0 [1] |
| 6-(2,4-Difluorophenyl)sulfonyl-2-(1H-indol-5-ylamino)-8-methylpyrido[2,3-d]pyrimidin-7-one | IC50 | 10000.0 [1] |
| 3,13-Diazahexacyclo[14.7.0.02,10.04,9.011,15.017,22]tricosa-1(16),2(10),4,6,8,11(15),17,19,21-nonaen-14-one | IC50 | 1000.0 [1] |
| Drak2-IN-1 | IC50 | 1800.0 [1] |
| N-[2-Hydroxy-3-(3-nitroso-1H-indol-2-yl)-1H-indol-5-yl]cyclopropanecarboxamide | IC50 | 140.0 [1] |
| N-[2-Hydroxy-3-(3-nitroso-1H-indol-2-yl)-1H-indol-5-yl]-3-methylbut-2-enamide | IC50 | 450.0 [1] |
| N-[2-Hydroxy-3-(3-nitroso-1H-indol-2-yl)-1H-indol-5-yl]-3,3-dimethylbutanamide | IC50 | 10000.0 [1] |
| N-[2-Hydroxy-3-(3-nitroso-1H-indol-2-yl)-1H-indol-5-yl]butanamide | IC50 | 510.0 [1] |
| 5,5-Dimethyl-8-[[4-(2,2,2-trifluoroethylamino)furo[3,2-d]pyrimidin-2-yl]amino]-1H-4,1-benzoxazepin-2-one | IC50 | 10000.0 [1] |
| (2Z)-2-[(3,4-Dihydroxyphenyl)methylidene]-5-methoxy-1-benzofuran-3-one | IC50 | 12150.0 [1] |
| (2Z)-2-[(3-Ethoxy-4-hydroxyphenyl)methylidene]-5-methoxy-1-benzofuran-3-one | IC50 | 18880.0 [1] |
| 3,13-Diazahexacyclo[14.8.0.02,10.04,9.011,15.017,22]tetracosa-1(16),2(10),4,6,8,11(15),17,19,21-nonaen-12-one | IC50 | 1000.0 [1] |
| 3,13-Diazahexacyclo[14.8.0.02,10.04,9.011,15.017,22]tetracosa-1(16),2(10),4,6,8,11(15),17,19,21-nonaene-12,14-dione | IC50 | 487.0 [1] |
| 2-(4-Nitrophenyl)-4-(3-pyridylmethylene)oxazole-5(4H)-one | IC50 | 291.2 [1] |
| 2-(2-Chloro-5-iodophenyl)-4-(pyridin-4-ylmethylene)oxazol-5(4H)-one | IC50 | 227.1 [1] |
| 2-(3,4-Difluorophenyl)-4-(3-pyridylmethylene)oxazole-5(4H)-one | IC50 | 346.1 [1] |
| N-[5-[6-(Methylamino)pyrazin-2-yl]-2-oxo-1H-pyridin-3-yl]-4-[(2S)-2-(pyrrolidin-1-ylmethyl)pyrrolidin-1-yl]benzamide | Ki | 1000.0 [1] |
| 2-(4-Methyl-3-nitrophenyl)-4-(3-pyridylmethylene)oxazole-5(4H)-one | IC50 | 533.5 [1] |
| 2-(4-Bromo-3-methylphenyl)-4-(3-pyridylmethylene)oxazole-5(4H)-one | IC50 | 278.5 [1] |
| 2-(3-Methoxyphenyl)-4-(3-pyridylmethylene)oxazole-5(4H)-one | IC50 | 395.3 [1] |
| 2-(3-Bromophenyl)-4-(3-pyridylmethylene)oxazole-5(4H)-one | IC50 | 148.4 [1] |
| 2-(2-Bromo-4-methoxyphenyl)-4-(3-pyridylmethylene)oxazole-5(4H)-one | IC50 | 157.0 [1] |
| 2-(3-Chlorophenyl)-4-(3-pyridylmethylene)oxazole-5(4H)-one | IC50 | 359.6 [1] |
| (4Z)-2-(4-Chloro-3-nitrophenyl)-4-(pyridin-3-ylmethylidene)-1,3-oxazol-5-one | IC50 | 278.5 [1] |
| 8-N-(Cyclopropylmethyl)-4-N-(2-methylsulfanylphenyl)-2-(4-piperidin-4-ylpiperazin-1-yl)pyrimido[5,4-d]pyrimidine-4,8-diamine | IC50 | 10000.0 [1] |
| 2-N-(1H-Indazol-6-yl)-4-N-(2,2,2-trifluoroethyl)furo[3,2-d]pyrimidine-2,4-diamine | IC50 | 4860.0 [1] |
| N~4~-Cyclopropyl-N~2~-(3-Methyl-1h-Indazol-6-Yl)furo[3,2-D]pyrimidine-2,4-Diamine | IC50 | 4980.0 [1] |
| 2-N-(3-Chloro-4-morpholin-4-ylphenyl)-4-N-(2,2,2-trifluoroethyl)furo[3,2-d]pyrimidine-2,4-diamine | IC50 | 10000.0 [1] |
| 3-Thia-13,23-diazahexacyclo[14.7.0.02,10.04,9.011,15.017,22]tricosa-1,4,6,8,10,15,17,19,21-nonaen-12-one | IC50 | 1000.0 [1] |